Advanced Functionalized CeO
2/Al
2O
3 Nanocomposite Sensor for Determination of Opioid Medication Tramadol Hydrochloride in Pharmaceutical Formulations.
NANOMATERIALS 2022;
12:nano12081373. [PMID:
35458081 PMCID:
PMC9025318 DOI:
10.3390/nano12081373]
[Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/25/2022] [Revised: 04/11/2022] [Accepted: 04/13/2022] [Indexed: 01/22/2023]
Abstract
BACKGROUND
The exceptional characteristics of cerium oxide (CeO2) and aluminum oxide (Al2O3) nanoscales have inspired significant attention to those nanocomposites as possible electroactive resources for applications of sensing and biosensing.
METHODS
In this research, an innovative new factionalized CeO2/Al2O3 nanocomposite membrane sensor was presented to assess tramadol hydrochloride (TRD) in marketable products.
RESULTS
Tramadol-phosphomolybdate (TRD-PM) was formed by mixing tramadol hydrochloride and phosphomolybdic acid (PMA) in the attendance of polymeric matrix and o-nitrophenyloctyl ether solvent mediator. With 1.0 × 10-10-1.0 × 10-2 mol L-1 as a range of linearity and EmV = (57.567 ± 0.2) log [TRD] + 676.29 as a regression equation, the functionalized sensor using TRD-PM-CeO2/Al2O3 nanocomposite showed great selectivity and sensitivity for the discriminating and measurement of TRD. Using the regression equation EmV = (52.143 ± 0.4) log [TRD] + 431.45, the unmodified coated wire sensor of TRD-PM, on the other hand, showed a Nernstian response between 1.0 × 10-6 and 1.0 × 10-2 mol L-1, Using the methodology's specified guidelines, the proposed improved potentiometric system was validated against several criteria.
CONCLUSION
The suggested method is suitable for the determination of TRD in its products.
Collapse